2024 TechKnow Invest Roadshow Conference Q&A with Dr Michael Baker of Arovella Therapeutics

UBI signs Henry Schein as US distribution partner for Xprecia

Imugene opens first Australian site for azer-cel trial

Adisyn Accelerates Graphene Revolution with New ALD Machine for Semiconductor Breakthroughs

Wotso acquires first property in Melbourne

Sigma welcomes the ACCC's decision on Chemist Warehouse

Quickstep Holdings Responds to ASDAM’s Takeover Offer Amid Strengthened Contract Wins

AVITA Medical Reports Strong Q3 Growth with RECELL GO Sales Surge and Prepares for New Product Launches

Archer's miniaturised Biochip gFET design improves foundry readiness

TrivarX’s new AI tool expands patient reach

Recce's Phase II ABSSSI clinical trial advances to final stages

Staff Writer 6 August, 2024

SHARE
SHARE

Rate video from Staff Writer: